Latest Artificial Intelligence News

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

Artrya Limited has successfully navigated a key FDA Q-Submission meeting, receiving clear guidance on the regulatory pathway for its Salix Coronary Flow module, with a 510(k) submission planned by year-end.

Hiremii Group has successfully raised $650,000 through an oversubscribed placement, underscoring strong investor confidence as it pushes forward with commercialising its AI-driven recruitment platform.

Pathkey.AI’s TrialKey platform continues to validate its AI-driven clinical trial success predictions, with September 2025 seeing an average 43.6% share price increase across flagged biotech stocks.

Redox Limited reported a 9.4% increase in sales revenue for FY25 despite challenging global conditions, while declaring a robust dividend payout that exceeds its policy. The company’s strategic focus on specialty chemicals, operational expansion, and ESG commitments positions it well for continued growth.

Imagion Biosystems has completed manufacturing its MagSense® HER2 imaging agent, progressing toward a Phase 2 clinical trial with strong collaborations and a recent AU$3.5 million capital raise.

Caprice Resources has significantly expanded its presence in Western Australia's Murchison Goldfields by acquiring the Comet Exploration Project, adding 40 kilometres of greenstone strike to its portfolio. This strategic move triples Caprice's landholding and sets the stage for accelerated exploration and potential new gold discoveries.

Unith Ltd reported an 18.8% increase in FY 2025 revenue to A$5.37 million alongside a significant capital raise, positioning itself for expansion in the burgeoning AI Digital Humans market.

Webjet Group has completed its acquisition of Locomote Holdings for $23 million, aiming to fast-track its digital business travel platform and reduce development risks. The move aligns with Webjet’s FY30 Strategic Plan to expand its footprint in corporate travel.

Vection Technologies reports a 60% revenue surge in 1H25, secures a $21 million equity raise, and strengthens its position in defence AI and spatial computing with a robust $75 million sales pipeline.

IMEXHS Limited has secured a significant one-year contract with Colombian cancer care provider Oncolife to deliver advanced radiology services, leveraging its integrated software and AI tools to enhance diagnostic precision.